JAMA Network
JAMA Dermatology Author Interviews
Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment. Our mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders.
Podcast'in sitesini ziyaret etmeyi ve yapımcısını desteklemeyi unutma: jamanetwork.com
Nereden dinlenir?
Uygulamada podcast'ler Replaio Radio Çok yakındaPodcast'ler çok yakında uygulamaya geliyor. Şimdi yükle ve podcast'lere yepyeni bir bakışı ilk gören sen ol
Bölümler
Treatment of Tattoos With a Picosecond Alexandrite Laser: A Prospective Trial 17.12.2012 7:36
Interview with Kenneth A. Arndt, MD and Jeffrey S. Dover, MD, FRCPC, authors of Treatment of Tattoos With a Picosecond Alexandrite Laser: A Prospective Trial
Deferasirox for Porphyria Cutanea Tarda: A Pilot Study 20.08.2012 11:31
Interview with Amit Pandya, MD, author of Deferasirox for Porphyria Cutanea Tarda: A Pilot Study
Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF PathwayToxicities Associated With Vemurafenib Treatment 21.05.2012 7:49
Interview with Lynn Cornelius, MD, author of Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF PathwayToxicities Associated With Vemurafenib Treatment.
Association of Increased Dermatologist Density With Lower Melanoma Mortality 20.02.2012 6:35
Interview with Jeremy S. Bordeaux, MD, MPH, author of Association of Increased Dermatologist Density With Lower Melanoma Mortality
The Impact of Pruritus on Quality of Life: The Skin Equivalent of Pain 17.10.2011 5:34
Interview with Laura K. DeLong, MD, MPH, and Suephy C. Chen, MD, MS, authors of The Impact of Pruritus on Quality of Life: The Skin Equivalent of Pain
Benzer podcast'ler
Replaio bir podcast yayıncısı değildir; program adları, kapak görselleri ve ses içerikleri yazarlarına aittir ve herkese açık RSS beslemeleri aracılığıyla dağıtılır